Wipfli Financial Advisors’s Filana Therapeutics FLNA Stock Holding History

Wipfli Financial Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Buy	+60	New	+$1.62K	﹤0.01%	2233

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wipfli Financial Advisors's FLNA Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Filana Therapeutics (FLNA) in Q3 2022: 60 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #2233 among its holdings.

175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

Wipfli Financial Advisors held 60 shares of Filana Therapeutics worth $3K as of Q3 2022.
Filana Therapeutics was a new Wipfli Financial Advisors position in Q3 2022.
Filana Therapeutics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2233 holding.
175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.